Clinical trial
A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
NCT03527472 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 23, 2018
- Completion date
- February 28, 2026
- Enrollment
- 111 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.